Viewing Study NCT00683657


Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2026-02-21 @ 11:35 PM
Study NCT ID: NCT00683657
Status: COMPLETED
Last Update Posted: 2015-06-01
First Post: 2008-05-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CV181-066
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators